Sluggish Biotech Stocks: Five Underlying Factors Plus A Sector Shift?

Both the biotech and healthcare sectors have been weak since the mid-October earnings release causing concerns about top line growth. Today the biotech sector tried to rally but with Nasdaq down they lost traction and were off their daily highs.